Bruker Corporation (BRKR) vs Smith & Nephew SNATS, Inc. (SNN)
- Bruker Corporation BRKR 61.31 +5.60%
- Smith & Nephew SNATS, Inc. SNN 31.21 −2.50%
Bruker Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $13.4B against $8.9B — 1.5× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Smith & Nephew SNATS, Inc. trades at 38.9×. Smith & Nephew SNATS, Inc. grew revenue faster over the last twelve months: 4.81% against 2.16%. Smith & Nephew SNATS, Inc. has the higher net margin (6.71% vs −4.76%) and the higher return on invested capital (0.00% vs −1.12%). Both pay a dividend; Smith & Nephew SNATS, Inc. yields more (2.49% vs 0.34%). Across the 22 metrics below, Smith & Nephew SNATS, Inc. leads on 20 and Bruker Corporation on 2.
Valuation
Profitability
| Metric | BRKR | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 47.66% | 70.52% | 57.76% |
| Operating margin | (1.99%) | 0.00% | (15.07%) |
| Net margin | (4.76%) | 6.71% | (14.45%) |
| Free cash flow margin | 6.97% | 0.00% | (3.88%) |
| Return on equity | (7.04%) | 0.00% | (10.35%) |
| Return on assets | (2.73%) | 0.00% | (17.26%) |
| Return on invested capital | (1.12%) | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack